Carl Zeiss Meditec AG Announces a US Clinical Trial of a New Minimally Invasive, All-Femto Laser Vision Correction Method

DUBLIN, Calif. & JENA, Germany--(BUSINESS WIRE)--Carl Zeiss Meditec announced its intention to initiate a US clinical trial of the ReLEx smile procedure for the correction of myopia, having received conditional approval for the trial from the US Food and Drug Administration (FDA).

Back to news